A pilot evaluation of external quality assessment of GenoType MTBDRplus versions 1 and 2 using dried culture spot material

Journal of Clinical Microbiology

Volumn 53, Issue 4, 2015, Pages 1365-1367

  Gous, N ^a   Isherwood, L E ^b   David, A ^b   Stevens, W ^a,b   Scott, L E ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; RIFAMPICIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; CULTURE MEDIUM; DRIED CULTURE SPOT; GENOTYPE; LIMIT OF DETECTION; MYCOBACTERIUM FORTUITUM; MYCOBACTERIUM INTRACELLULARE; MYCOBACTERIUM KANSASII; MYCOBACTERIUM TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS TEST KIT; NONHUMAN; PILOT STUDY; PRIORITY JOURNAL; QUALITY CONTROL; VALIDITY; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MOLECULAR DIAGNOSIS; MYCOBACTERIUM; PROCEDURES; SENSITIVITY AND SPECIFICITY; SPECIES DIFFERENCE; STANDARDS;

BACTERIA (MICROORGANISMS); CORYNEBACTERINEAE; LONCHOCARPUS GLAUCIFOLIUS; MYCOBACTERIUM;

BACTERIOLOGICAL TECHNIQUES; GENOTYPE; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; MYCOBACTERIUM; PILOT PROJECTS; SENSITIVITY AND SPECIFICITY; SPECIES SPECIFICITY;

EID: 84925251181     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.03340-14     Document Type: Article

References (11)

1. World Health Organization. 2007. Policy and procedures of the WHO/NICD Microbiology External Quality Assessment Programmein Africa: years to 4 (2002-2006). World Health Organization, Geneva, Switzerland. http://whqlibdoc.who.int/hq/2007/who-cds-epr-lyo-2007.3-eng.pdf.
2. World Health Organization. 2011. Overview of external quality assessment (EQA): module 10, content sheet 10-1. World Health Organization, Geneva, Switzerland. http://www.who.int/ihr/training/laboratory-quality/10-b-eqa-contents.pdf.
3. Parsons LM, Somoskovi A, Gutierrez C, Lee E, Paramasivan CN, Abimiku A, Spector S, Roscigno G, Nkengasong J. 2011. Laboratory diagnosis of tuberculosis in resource-poor countries: challenges and opportunities. Clin Microbiol Rev 24:314-350. http://dx.doi.org/10.1128/CMR.00059-10.
4. Noble MA. 2013. An overview of the essential elements of a PT/EQA program. U.S. Centers for Disease Control and Prevention, Atlanta, GA.
5. Quality Control for Molecular Diagnostics. 2015. EQA programmes. Quality Control for Molecular Diagnostics, Glasgow, Scotland. http://www.qcmd.org/index.php?pageId=3&pageVersion=EN.
6. UK National External Quality Assessment Service for Microbiology. 2013. Schemes. UK NEQAS for Microbiology, London, United Kingdom. http://www.ukneqasmicro.org.uk/index.php/schemes.
7. Scott LE, Gous N, Cunningham BE, Kana BD, Perovic O, Erasmus L, Coetzee GJ, Koornhof H, Stevens W. 2011. Dried culture spots for Xpert MTB/RIF external quality assessment: results of a phase 1 pilot study in South Africa. J Clin Microbiol 49:4356-4360. http://dx.doi.org/10.1128/JCM.05167-11.
8. Scott L, Albert H, Gilpin C, Alexander H, DeGruy K, Stevens W. 2014. Multicenter feasibility study to assess external quality assessment panels for Xpert MTB/RIF assay in South Africa. J Clin Microbiol 52:2493-2499. http://dx.doi.org/10.1128/JCM.03533-13.
9. Helb D, Jones M, Story E, Boehme C, Wallace E, Ho K, Kop J, Owens MR, Rodgers R, Banada P, Safi H, Blakemore R, Lan NT, Jones-Lopez EC, Levi M, Burday M, Ayakaka I, Mugerwa RD, McMillan B, Winn-Deen E, Christel L, Dailey P, Perkins MD, Persing DH, Alland D. 2010. Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology. J Clin Microbiol 48:229-237. http://dx.doi.org/10.1128/JCM.01463-09.
10. Gous N, Cunningham B, Kana B, Stevens W, Scott LE. 2013. Performance monitoring of Mycobacterium tuberculosis dried culture spots for use with the GeneXpert system within a national program in South Africa. J Clin Microbiol 51:4018-4021. http://dx.doi.org/10.1128/JCM.01715-13.
11. Lawn SD, Kerkhoff AD, Vogt M, Ghebrekristos Y, Whitelaw A, Wood R. 2012. Characteristics and early outcomes of patients with Xpert MTB/RIF-negative pulmonary tuberculosis diagnosed during screening before antiretroviral therapy. Clin Infect Dis 54:1071-1079. http://dx.doi.org/10.1093/cid/cir1039.